Partner Content Partner Content How Will Spark’s Approval Impact the Gene Therapy Field? Gene Therapy for Rare Disorders Summit
Partner Content Partner Content 7th Annual HPAPI Summit - Boston 2018 Explore Unique Potent Compound Case Studies
Partner Content Partner Content Microbiome Drug Development Boston - Your Invite Pioneering The Microbiome Into Effective Medicines
Events Partner Content Microbiome Drug Development Boston 2018 Pioneering The Microbiome Into Effective Medicines
Debates & Insight Sponsored Standing on the cusp of something great: How real-world data... REAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care
Events Partner Content Personalized and Precision Medicine International Conference... Int. Conference on Personalized and Precision Medicine
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
